Company page
Amgen Inc.
Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. With a market capitalization of approximately $197.7 billion, Amgen is recognized for its commitment to advancing science and improving patient outcomes. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.

- Ticker
- AMGN:NASDAQ
- Asset type
- Stock
- Market cap
- $233.78B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD